Shares of Surgery Partners Inc. (NASDAQ:SGRY) have been given an average recommendation of “Buy” by the eight brokerages that are currently covering the firm. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $21.00.

Several equities analysts have recently issued reports on SGRY shares. Zacks Investment Research cut shares of Surgery Partners from a “buy” rating to a “hold” rating in a research note on Tuesday. Jefferies Group reaffirmed a “buy” rating and issued a $27.00 price objective on shares of Surgery Partners in a research note on Wednesday, August 10th.

In other news, VP Jennifer Baldock sold 2,500 shares of Surgery Partners stock in a transaction that occurred on Monday, August 29th. The shares were sold at an average price of $19.20, for a total value of $48,000.00. Following the transaction, the vice president now directly owns 66,983 shares of the company’s stock, valued at $1,286,073.60. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 7.10% of the stock is currently owned by insiders.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Peregrine Capital Management LLC purchased a new position in Surgery Partners during the third quarter valued at $21,701,000. Neuberger Berman Group LLC bought a new position in shares of Surgery Partners during the second quarter worth approximately $19,143,000. Cortina Asset Management LLC bought a new position in shares of Surgery Partners during the second quarter worth approximately $12,327,000. Vaughan Nelson Investment Management L.P. increased its position in shares of Surgery Partners by 24.6% in the second quarter. Vaughan Nelson Investment Management L.P. now owns 2,752,850 shares of the company’s stock worth $49,276,000 after buying an additional 543,100 shares during the last quarter. Finally, Stonerise Capital Management LLC bought a new position in shares of Surgery Partners during the first quarter worth approximately $5,304,000. 38.34% of the stock is currently owned by institutional investors and hedge funds.

Surgery Partners (NASDAQ:SGRY) opened at 17.40 on Tuesday. Surgery Partners has a 1-year low of $11.76 and a 1-year high of $22.32. The firm’s 50-day moving average is $18.13 and its 200-day moving average is $17.28. The stock has a market cap of $835.53 million and a P/E ratio of 89.69.

Surgery Partners (NASDAQ:SGRY) last announced its quarterly earnings data on Wednesday, November 9th. The company reported $0.21 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.14 by $0.07. The company had revenue of $282.70 million for the quarter, compared to analysts’ expectations of $283.80 million. Surgery Partners had a net margin of 2.60% and a return on equity of 17.09%. The business’s revenue was up 18.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.04 EPS. On average, analysts forecast that Surgery Partners will post $0.66 EPS for the current year.

Surgery Partners Company Profile

Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.

5 Day Chart for NASDAQ:SGRY

Receive News & Stock Ratings for Surgery Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners Inc. and related stocks with our FREE daily email newsletter.